SORRENTO THERAPEUTICS
Sorrento Therapeutics is a development-stage biopharmaceutical company engaged in the acquisition, discovery, development and commercialization of proprietary drug therapeutics for addressing significant unmet medical needs. Sorrentoโs late stage pipeline include Cynviloqโข (paclitaxel in polymeric micelle formulation) currently in a registrational bio-equivalent study versus albumin-bound paclitaxel; and Resiniferatoxin (RTX),which is in a Phase 1/2 study at the NIH to treat terminal can... cer patients suffering from intractable pain. Sorrento has one of the industryโs most diverse antibody (G-MABยฎ) library comprised of high-quality, fully human antibodies with a diversity of more than ten trillion (>10^16). Along with its' proprietary conjugation chemistries and novel toxins, Sorrento has all in-house capabilities to generate and develop a new generation of homogenous ADCs with well-defined drug antibody ratios (DAR) in contrast to approved ADCs, which are heterogeneous mixtures with different DARs. These differentiating characteristics may lead to improved ADC stability and pharmacokinetics while reducing off-target effects compared to existing ADCs. Sorrento's primary therapeutic focus is cancer although its products and technologies have much broader clinical applications including autoimmune disorders, metabolic diseases and infectious diseases.
SORRENTO THERAPEUTICS
Industry:
Biopharma Biotechnology Health Care Medical Pharmaceutical
Founded:
2006-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.sorrentotherapeutics.com
Total Employee:
101+
Status:
Active
Contact:
(858) 210-3759
Email Addresses:
[email protected]
Total Funding:
264.42 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
Date | Company | Article | Price |
---|---|---|---|
2022-07-07 | Ancora Medical Technology | Ancora Medical Technology acquired by Sorrento Therapeutics | N/A |
2021-04-05 | ACEA Therapeutics | ACEA Therapeutics acquired by Sorrento Therapeutics | 38 M USD |
2020-07-24 | SmartPharm Therapeutics | SmartPharm Therapeutics acquired by Sorrento Therapeutics | N/A |
2016-08-15 | Semnur Pharmaceuticals | Semnur Pharmaceuticals acquired by Sorrento Therapeutics | N/A |
2016-08-08 | Scilex Pharmaceuticals | Scilex Pharmaceuticals acquired by Sorrento Therapeutics | N/A |
Investors List
Ally Bridge Group
Ally Bridge Group investment in Post-IPO Equity - Sorrento Therapeutics
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2021-08-05 | Aardvark Therapeutics | Sorrento Therapeutics investment in Series B - Aardvark Therapeutics | 29 M USD |
2021-07-19 | Celularity | Sorrento Therapeutics investment in Post-IPO Equity - Celularity | 80 M USD |
2018-02-15 | Celularity | Sorrento Therapeutics investment in Venture Round - Celularity | 250 M USD |
2015-01-31 | Globavir | Sorrento Therapeutics investment in Venture Round - Globavir | 4 M USD |
2015-01-01 | NantiBodyFc | Sorrento Therapeutics investment in Private Equity Round - NantiBodyFc | 10 M USD |
Official Site Inspections
http://www.sorrentotherapeutics.com Semrush global rank: 868.79 K Semrush visits lastest month: 43.24 K
- Host name: 147.108.198.104.bc.googleusercontent.com
- IP address: 104.198.108.147
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043

More informations about "Sorrento Therapeutics"
Sorrento Therapeutics - Crunchbase Company Profile โฆ
Contact Email [email protected] Phone Number (858) 210-3759 Sorrento Therapeutics is a development-stage biopharmaceutical company โฆSee details»
Sorrento Therapeutics, Inc. | LinkedIn
Sorrento Therapeutics, Inc. is a clinical stage and commercial biopharmaceutical company focused on delivering innovative and clinically meaningful therapies to address unmet medical โฆSee details»
Sorrento Therapeutics - Overview, News & Similar companies
Feb 22, 2023 Sorrento Therapeutics contact info: Phone number: (858) 203-4100 Website: www.sorrentotherapeutics.com What does Sorrento Therapeutics do? Founded in 1989, โฆSee details»
Org Chart Sorrento Therapeutics - The Official Board
Www.sorrentotherapeutics.com. has 24 executives and 1 subsidiary +1 858 210 3700; Add an executive. Sorrento Therapeutics (SRNE) News . Anything missing? We search for you. Print โฆSee details»
Sorrento Therapeutics - Craft
Oct 29, 2024 Sorrento Therapeutics has 5 employees across 2 locations and $62.84 m in annual revenue in FY 2022. See insights on Sorrento Therapeutics including office locations, โฆSee details»
Sorrento Therapeutics, Inc. Information - RocketReach
Sorrento Therapeutics, Inc. is a clinical stage and commercial biopharmaceutical company focused on delivering innovative and clinically meaningful therapies to address unmet medical โฆSee details»
Sorrento Therapeutics - AnnualReports.com
Sorrento Therapeutics is an antibody-centric, clinical stage biopharmaceutical company developing new treatments for cancer, inflammation and autoimmune diseases.See details»
Sorrento Therapeutics, Inc. (SRNE) - Yahoo Finance
See the company profile for Sorrento Therapeutics, Inc. (SRNE) including business summary, industry/sector information, number of employees, business summary, corporate governance, โฆSee details»
Sorrento Therapeutics, Inc. Company Overview, Contact Details ...
Oct 9, 2019 [email protected]: 2%. [email protected]: [email protected]: 1%. See more formats. Frequently Asked Questions โฆSee details»
Sorrento Therapeutics Company Description - Stock Analysis
Apr 27, 2023 Sorrento Therapeutics, Inc., a clinical and commercial stage biopharmaceutical company, develops a portfolio of next-generation treatments for three therapeutic areas: โฆSee details»
Sorrento Therapeutics - VentureRadar
"Sorrento is a clinical stage, antibody-centric, biopharmaceutical company developing new treatments for cancer, pain and COVID-19. Sorrento's extensive immuno-oncology platforms โฆSee details»
SORRENTO THERAPEUTICS, INC.
Of incorporation or organization) (Commission File Number) IRS Employer Identification No.) Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) โฆSee details»
Sorrento Therapeutics - PitchBook
Sorrento Therapeutics General Information Description. Sorrento Therapeutics Inc is a clinical and commercial-stage biopharmaceutical company developing a portfolio of next-generation โฆSee details»
Sorrento Therapeutics Company Profile | Management and
SQL International Organization for Standardization . Lua PUC-Rio . HTML Web Hypertext Application Technology Working Group . PHP PHP . Web Analytics ...See details»
Sorrento Therapeutics Company Profile -Sales, Contacts, โฆ
Www.sorrentotherapeutics.com: There are 3 Companies located at 9380 JUDICIAL DR, San Diego, CA 92121 ... View larger map Directions. Business Description Sorrento Therapeutics โฆSee details»
Sorrento Therapeutics - Golden
Sorrento Therapeutics is a publicly owned, anti-body centric, clinical stage biopharmaceutical company based in San Diego, California.It develops new treatments for cancer, inflammation, โฆSee details»
Contact - Sorrento Therapeutics
Sorrento Therapeutics, Inc. 4955 Directors PlaceSan Diego, CA 92121 Tel: (858) 203-4100Fax: (858) 203-4028 [email protected] Clinical โฆSee details»
Working At Sorrento Therapeutics: Company Overview and โฆ
Mar 14, 2024 sorrentotherapeutics.com. Organization Type. Public. Social Media. Sorrento Therapeutics is a development-stage biopharmaceutical company engaged in the acquisition, โฆSee details»
Sorrento Completes Acquisition of ACEA Therapeutics,
Jun 2, 2021 For more information visit www.sorrentotherapeutics.com. ... drug discovery efforts to encompass development in both targeted and immunotherapy areas. Alongside a robust โฆSee details»
Linking Policy - Sorrento Therapeutics
If you are interested in linking to this website or any other SORRENTO owned websites, please notify SORRENTO by sending an e-mail to [email protected]. Include your โฆSee details»